Covered in this report
The report covers the present scenario and the growth prospects of the global metabolic disorders therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of various metabolic disorders including diabetes, obesity, lysosomal storage diseases, and hypercholesterolemia.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Related reports by Radiant Insights: http:// www. radiantinsights. com / catalog / healthcare
Global Metabolic Disorders Therapeutics Market 2016-2020, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Novo Nordisk
• Sanofi
• Merck
• AstraZeneca
• Eli Lilly
Other prominent vendors
• AbbVie
• Actelion Pharmaceuticals
• Adocia
• Aegerion Pharmaceuticals
• Akros Pharma
Follow Us: